A genetic basis for RA susceptibility is suggested by the known familial tendency to develop this disease and by a higher concordance rate for RA in monozygotic twins than in dizygotic twins. ' The relatively low figure of 32% concordance for RA development in monozygotic twins gives a clear indication of the role of non-genetic 'environmental' factors contributing to the disease development.
A major component of the genetic susceptibility to RA has been shown to be encoded within the HLA Immunoglobulin allotypes (Gm, Am, and Km) were identified by haemagglutination inhibition assays of serum samples2o and included Glm (z,a,x,f), G2m(n), G3m(g,bO,bl,b3,b5,s,t,c3,c5), A2m (1, 2) , and the x light chain allotypes Km (1, 3) . G3m(bO,bl,b3, and b5) usually occur together and are summarised as G2m(b).
HLA typing was verformed using procedures described elsewhere. 28 STATISTICAL ANALYSIS X2 Analysis was used to compare phenotype frequencies seen in the unrelated index cases and normal controls. Levels of significance were not corrected for the number of comparisons made.
Similarly, the phenotype frequencies were compared for the index cases and other affected and non-affected individuals within the families. A formal cosegregation analysis was then undertaken X2=1-92, p=NS. (Tables 3 and 4) . f;n;bc3c' 6.3 (17) zaxf;n;g 0.0 (1) zaxf;n;gb 6-5 (4) 9-1 (72) 7-5 (9) 7-8 (7) 5-2 (14) zaxf;..; zaf;-.;gb 14.5 (9) 8-3 (66) (14) 10-1 (9) 10.0 (27) zaf;n;gb 16 See ref 29. tIncluding index cases.
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Values are percentages (Nos). Rare phenotypes discussed in ref 29. particular Gm phenotype in patients with RA was seen. The Gm frequencies in all patients with RA and published controls were remarkably similar.
The immunoglobulin x light chain allotype Km(1) was present in index cases and affected family members at frequencies of 11-4% and 11-3% respectively. A frequency of 17*9% for Km(1) has been reported for unaffected controls.24 No significant differences were seen between patients with RA and controls for the frequencies of the IgA allotypic markers Am(1) or Am (2) .
An interesting observation is that, of the 46 PiZ individuals, 39 had Gm phenotypes containing the Glm(z) and (a) allotypes (X2=16-6, p<0-001) and 19 the Gm(zax;g) haplotype (X2=15-0, p<0001).
Such associations may reflect linkage disequilibria between these alleles.
An analysis of the relation between DR4 status and Gm allotypes in patients with RA failed to show any increase in the proportion of Glm(z) or Glm(x) allotypes in DR4 positive patients compared with those who were DR4 negative (Table 6 ). Such an analysis for Pi markers, however, showed a higher proportion of PiZ and PiS containing phenotypes in DR4 positive patients than in those who were DR4 negative (Table 7) . Glm(z) positive 21 13 Glm(z) negative 19 7 Glm(x) positive 7 5 Glm(x) negative 33 15 No significant associations. 16 3 PiS or PiZ negative 24 18 X2=4-2, p<O005.
Discussion
In keeping with some other studies we have observed an increase in the frequency of Pi*Z in patients with RA and, additionally, have shown an increase in the frequency of Pi*S. Other workers have, however, shown no such association. Interestingly, the current study found higher frequencies of PiZ (11.1%) and PiS (17-5%) than a similar but larger series recently published, which found 1-4% and 9-7% respectively, neither of which was significantly increased compared with controls.20 It is difficult to explain the disparity in these results, but one possible factor is that the index cases in the current study were drawn from multicase families and from sporadic cases in the latter. Thus Pi would appear to 'contribute' towards RA susceptibility. It is known that these particular Pi variants, present at low frequency in the normal population, are associated quantitatively with different levels of serum a, antitrypsin. When the concentration of a, antitrypsin is expressed as a percentage of that found in the PiMM genotype (i.e., 100%) reduced levels are found for MS (88-80%), MZ (67-59%2), SS (58%), SZ (37-36%), and ZZ (7-16%). 3 No quantitative differences have been reported for Ml and M2 subtypes. There is variation between individuals with the same Pi type, however, and some overlap of levels may exist, dependent on the individuals examined.
A reduction in the at antitrypsin level should have the effect of increasing the action of proteolytic enzymes. a, Antitrypsin is a major inhibitor of elastase, and it has been suggested that any reduction in its level could lead to increased destruction of joint cartilage by leucocyte elastase released by infiltrating cells during inflammatory rheumatoid processes.s Associations between Pi*Z and a variety of pulmonary disorders have been described,30 tl including patients with RA and fibrosing alveolitis19 and individuals with emphysema.32 These observations, together with the suggestions of increased proteolytic enzyme activity, predict an increase of pulmonary problems or disease severity, or both, in family RA cases with the PiZ variant. Unfortunately the sample size in this study may be too small to address this problem satisfactorily.
The increase of the MS phenotype frequency in patients with RA and its subsequent reduction in unaffected individuals underlines its possible contribution to RA susceptibility. We were unable to show, however, that the observed distortion in the cosegregation of either S or Z with RA in these families is significant. The high frequency of Pi*Z in all groups of family members, including unaffected members, is unexpected. There have been several reports of a positive transmission bias of PiZ alleles from men,5 F3 and this may go some way towards explaining this observation. Thus PiZ bearing haplotypes could represent a susceptibility factor contributing towards RA development for certain individuals and through this mechanism of 'loading the dice' may be carried in their family members more frequently than expected by chance.
No particular Gm allotype was raised in frequency for any set of individuals in these families with RA. Associations were seen, however, between certain Pi variants and Gm allotypes and haplotypes. The obvious explanation for this finding is that linkage disequilibrium exist between these alleles. Although it has been shown that Pi and Gm are linked,6 the recombination fraction between them is estimated to be 026,5 and it would be unusual for linkage disequilibria to be maintained over this distance. An analogy has been drawn between the observed transmission bias of PiZ containing haplotypes and the effects of the T locus in the mouse,5 which can disturb both segregation ratios and recombination distances between genes.34 Thus it is not impossible to find certain alleles some distance apart which maintain the phenomenon of linkage disequilibnum.
Previous studies have shown an increase of the Glm(x) allotype in DR4 positive RA patients, implying some level of interaction with the HLA system.'4 15 This relation could not be observed in our data. A similar situation can be seen, however, whereby significantly more PiS and PiZ containing phenotypes are present in DR4 positive patients than in DR4 negative ones. As linkage disequilibrium appears to exist between Gm(zax;g) and PiZ, a reconciliation between these observations may be that certain chromosome 14 Pi-Gm haplotypes can interact with certain chromosome 6 HLA haplotypes to confer greater RA susceptibility on individuals. Several hypotheses may explain the contribution of chromosome 14 encoded products to RA susceptibility. One is that Pi may have a direct role in RA pathogenesis and that Gm allotypes, such as Glm(x), may be 'innocent bystanders' carried along through linkage disequilibria. Alternatively, it can be argued that Gm allotypes directly affect the generation of rheumatoid factors.
Another explanation could be that an RA susceptibility gene(s) is in linkage disequilibrium with certain Pi and Gm alleles and could be found more commonly in certain haplotypes. This would not necessarily mutually exclude an additional involvement of Pi and Gm in RA. T cell receptor genes are now known to be encoded also on chromosome 
